PhD position in PET imaging in diabetes and oncology
Sort on published: 2018-12-20
Uppsala University is a comprehensive research-intensive university with a strong international standing. Our mission is to pursue top-quality research and education and to interact constructively with society. Our most important assets are all the individuals whose curiosity and dedication make Uppsala University one of Sweden’s most exciting workplaces. Uppsala University has 42,000 students, 7,000 employees and a turnover of SEK 6.7 billion.
The research group Theranostics is located by the Rudbeck Laboratory, and close to the Biomedical Center (BMC) and the Uppsala University Hospital. Olof Eriksson’s lab is associated with Science for Life Laboratory and focuses on development of molecular imaging methodologies for improved diagnosis, management and treatment of metabolic disease and cancer (https://www.scilifelab.se/researchers/olof-eriksson). The research group is a part of the Department of Medicinal Chemistry (www.ilk.uu.se).
Project description/ duties:
The aim of the project is to develop and evaluate PET radiopharmaceuticals for in vivo molecular imaging of inflammatory processes and beta cell mass. The radiopharmaceuticals will be used to study disease processes in models of diabetes and cancer. The radiopharmaceutical development includes radiochemistry, in vitro evaluation (cells and autoradiography) and in vivo evaluation (PET imaging, image analysis, biodistribution and dosimetry). Apart from research, the PhD student may participate in teaching and routine maintenance of the lab.
We are looking for a highly motivated student for a PhD position. We welcome applications from candidates that already have, or who expect to soon have, a Master of Science degree in biomedicine, engineering, chemistry, natural sciences, pharmacy, medicine or similar.
Experience of laboratory work including radiochemistry, in vitro (cells/ autoradiography) and in vivo (biodistribution, PET/SPECT/CT/MRI imaging, image analysis) evaluation of radiopharmaceuticals is an advantage. Completed courses in laboratory animal science (e.g. FELASA C) or radiation protection are an advantage. The applicant must be fluent in English with excellent communication skills.
A person meets the general admission requirements for third-cycle courses and study programmes if he or she:
- has been awarded a second-cycle qualification, or
- has satisfied the requirements for courses comprising at least 240 credits of which at least 60 credits were awarded in the second cycle, or
- has acquired substantially equivalent knowledge in some other way in Sweden or abroad.
The application should be written in English and contain a cover letter describing the applicant’s research interests, an updated CV including a list of previous publications (if any), as well as copies of diplomas and certificates of higher academic degrees. Also include information about previous experience of research and why you would like to be enrolled as a PhD student. Please also attach contact details (name, e-mail, phone number) to at least two referees and/or letters of recommendation.
Selection of candidates is based on qualifications, previous work and/or research experience within the field, and personal suitability. Shortlisted candidates will be called for interviews as soon as possible after the application deadline. The enrolment will then be approved by the Medicine and Pharmacy disciplinary domain at Uppsala University.
Information about education at the postgraduate level, admission requirements and admission decisions can be found at http://www2.medfarm.uu.se/utbildning/forskarniva/vill_du_borja/
Rules governing PhD candidates are set out in the Higher Education Ordinance Chapter 5, §§ 1-7 and in Uppsala university's rules and guidelines.
Uppsala University strives to be an inclusive workplace that promotes equal opportunities and attracts qualified candidates who can contribute to the University’s excellence and diversity. We welcome applications from all sections of the community and from people of all backgrounds.
Salary: According to local agreement for PhD students and teaching assistants.
Starting date: 2019-04-01 or as soon as possible thereafter
Position: The graduate program covers four years of full-time study. The position can be combined with teaching or other duties at the department (maximum 20%), which prolongs the employment with the corresponding time.
Type of Position: 100 %
For further information about the position please contact
Associate Senior Lecturer Olof Eriksson (email@example.com) or Head of Department Anders Karlén (firstname.lastname@example.org)
Please submit your application by February 1st 2019, UFV-PA 2018/4728.
We decline offers of recruitment and advertising help. We only accept the application the way described in the advertisement.
Placement: Department of Medicinal Chemistry
Type of employment: Full time , Temporary position longer than 6 months
Pay: Fast lön
Number of positions: 1
Working hours: 100 %
County: Uppsala län
Ellena Papaioannou, Seko
Suzanne Borén Andersson, TCO/ST 018-471 6251
Per Sundman, Saco-rådet 018-471 1485
Number of reference: UFV-PA 2018/4728
Last application date: 2019-02-01